PhorMed is a clinical stage biopharmaceutical company.
PhorMed has raised $239K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in August 2022.
PhorMed's investors include Meyer Global.
PhorMed is headquartered in Beverly Hills, United States.
PhorMed is a clinical stage biopharmaceutical company.
PhorMed is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhorMed — Funding & Investors." VCBacked, August 18, 2022, https://www.vcbacked.co/company/phormed. Accessed September 30, 2026.
VCBacked. (2022). PhorMed — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/phormed
{{cite web |title=PhorMed — Funding & Investors |url=https://www.vcbacked.co/company/phormed |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated